BCRX Gross Profit Growth
Biocryst Pharmaceuticals Inc · Gross Profit Growth
BCRX Gross Profit Growth
Year-over-year change vs the same period a year earlier
Latest reported-59.10%period ending
BCRX TTM Gross Profit YoY % (-36.36% → -59.10%)
Year-over-year change
High-resolution chart · PNG
BCRX gross profit growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Gross Profit Growth |
|---|---|
| -59.0968% | |
| -65.6987% | |
| 95.0398% | |
| 44.2364% | |
| 43.6341% | |
| 39.2264% | |
| 34.1661% | |
| 29.7126% | |
| 26.0695% | |
| 24.0871% | |
| 23.6602% | |
| 33.3926% | |
| 47.7792% | |
| 51.4803% | |
| 76.3081% | |
| 118.4849% | |
| 183.5805% | |
| 660.3353% | |
| 828.7928% | |
| 116.9304% | |
| 53.1352% | |
| -45.6207% | |
| -63.929% | |
| 382.0295% | |
| 369.2075% | |
| 117.3182% | |
| 121.653% | |
| -51.8934% | |
| -63.7381% | |
| 14.1387% | |
| -14.0606% | |
| -18.9304% | |
| 3.7162% | |
| -35.2071% | |
| -0.7187% | |
| 21.0029% | |
| 11.209% | |
| -36.7484% | |
| -48.9787% | |
| -54.0211% | |
| -14.5631% | |
| 1,062.2904% | |
| 10,202.4444% | |
| 742.9618% | |
| 176.1692% | |
| -59.4302% | |
| -95.2622% | |
| 84.6915% | |
| 414.8566% | |
| 75.9775% | |
| -32.5857% | |
| -80.0985% | |
| -92.7446% | |
| -79.776% | |
| -28.2747% | |
| -51.0492% | |
| -28.9455% | |
| -36.6892% | |
| -68.4677% | |
| -67.5747% | |
| -59.9326% | |
| -54.4625% | |
| -11.065% | |
| 77.9059% | |
| 80.757% | |
| 82.7858% | |
| 23.8397% | |
| 6.8157% | |
| -15.7609% | |
| -31.1537% | |
| -20.6021% | |
| 11.814% | |
| 134.3291% | |
| 398.9877% | |
| 1,046.9753% | |
| 990.8064% | |
| 1,011.9402% | |
| 1,555.4578% | |
| 3,989.7206% | |
| 2,168.9094% | |
| 6,184.4437% | |
| 347.8733% | |
| -54.9224% | |
| -113.2868% | |
| -97.4005% | |
| -86.9342% | |
| -79.3818% | |
| 29.993% | |
| 8.1182% | |
| -2.3663% | |
| -7.919% | |
| -76.0271% | |
| -82.7568% | |
| -85.9598% | |
| -84.0959% | |
| -17.487% | |
| 189.5658% | |
| 3,995.8821% | |
| 153.9971% | |
| -8.0997% |